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cDNA clones for human phosphoribosyl pyrophosphate synthetase subunit II (PRS II) were isolated. The five overlap- 
ping clones contained 2457 base pairs (bp) covering a 9%bp complete coding region for 318 amino acid residues. Homol- 
ogies between human and rat PRS II were 99% of the amino acids and 88% of the nucleotides in the coding region. This 
amino acid homology seems to be the highest so far reported for enzymes involved in nucleotide metabolism and glycoly- 
sis. The highly conserved structure may be required for unique catalysis and rigid regulation of this enzyme. 
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1. INTRODUCTION 
5Phosphoribosyl 1-pyrophosphate (PPRibP), 
an essential substrate and a critical regulator in the 
pathways of purine, pyrirnidine [l] and pyridine 
nucleotide production, is synthesized from 
MgATP and ribose 5-phosphate, by the catalysis 
of PPRibP synthetase (EC 2.7.6.1). This enzyme 
exists in many active forms of various molecular 
masses and has many effecters: Mg2+ and in- 
organic phosphate (Pi) as activators; and ADP, 
2,3-bisphosphoglycerate or GDP as competitive or 
non-competitive inhibitors [2]. Recently, we show- 
ed that rat PPRibP synthetase had two distinct 
types of subunits, referred to as PRS I and PRS II, 
determined by cDNA cloning [3] and that human 
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The nucleotide sequence presented here has been submitted to 
the EMBL/GenBank database under the accession o. YOO971 
PRS I and PRS II genes (PRPSl and PRPS2, 
respectively) are located on different regions of the 
same X chromosome [4]. We now report the 
cDNA sequence for human PRS II. The high 
amino acid homology of the human and rat PRS 
II was compared with those of other human and 
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Fig.]. Restriction map and sequence strategies for human 
PPRibP synthetase subunit II cDNA. The box represents the 
coding region, the bar denoting the non-coding region. 
Numbers on the left indicate clone numbers. Arrows show the 
direction and extent of nucleotide sequencing. Sites of Sau3AI 
(0) were used for the sequencing. The broken lines indicate 
regions with different restriction maps. These regions may have 
been unrelated fragments, accidentally ligated during 
construction of the cDNA library. 
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murine enzymes. Additionally, knowledge of the poly(A)+ RNA in hgtl0 phage vector, as described [3]. Filters 
human cDNA paves the way for elucidation of the 
molecular basis of human X-linked disease: 
PPRibP synthetase superactivity [5-S]. 
2. MATERIALS AND METHODS 
were hybridized with a nick-translated fragment of rat PRS II 
cDNA (BstEll/NinclI, 1.50 kb) [3,4] as a probe, and washed in 
0.3 M NaCl, 0.03 M sodium citrate and 0.1% SDS at 68°C. 
Nucleotide sequencing of cDNA obtained was performed as 
described [3]. 
We reported the cloning of human PRS 11 cDNA [4]. Briefly, 
a cDNA library was constructed from adult human testis 
3. RESULTS AND DISCUSSION 
Fourteen clones were selected from 1350000 
-60 CGCTGTn;CCTCCGCCACCTCCTCCGCCGCCGCGCGCCCCTCGGAGTTCCGCGCCCCACC 
1 
M P N IVLFSGSSHQDLSQRVADRLGLELGKV 
ATGCCCAACATCGTGCTGTTCAGCGGCAGCTCGCATCAGGACCTATCCCAGCGCGTGGCCGACCGCCTGGGCCTGGA GCTGGGCAAGGTG 
VTKKFSNQE TSVEIGESVRGEDVYIIQSGC 
GTCACGAAGAAGTTCAGCAACCAGGAGACCAGCGTGGAGAl-TGGlGAAAGCGTGAGA GGGGAAGATGTCTACATCATCCAGAGCGGCTGC 
G E INDNLHELLIUINACKIASSSRVTAVIP 
GGGGAAATTMCGACAACCA~M~~CATCAn;A 
CFPYARQ DKKDKS RAPISAKLVANMLSVAG 
TGTTTCCCATACGCCCGACAAGATAAAAAGGACAAGAGTCGTGCCCCAA~ CTTGTGGCCMTATGCTGTCGG~ 
A D H I I T U D L H A S Q I QGFFDIPVDNLYAEPA 
GCGGATCACATCATCACCATGGACCIY;CA~;CTTCTCAGA lTCFFTGATAlTCCTGTGGATAATl’TGTATGCGGAGCCCGCA 
V L Q W I R E N IHE WMN CIIVSPDAGGAKRVTS 
GTCCPGCAGn;GATPCGGGAC~AGn;GAAGM 
I ADRLNVEFAL IHKERKKANEVDRNVLVGD 
ATTGCAGACAGGTTGAATGTGGAA- ATCCACAAAGAGAGGAAGAAGGCGAA TGAAGTGGACCGGAlGGTCCAC 
VKDRVAILVDDUADTCGTICHAADKLLSAG 
Gn;MGGACCGn;n;GCCATCCTCGn;GAn;ACAn;GCn; CACCATCTGCCATGC AcMGcTGcIy;TCAGCTGGA 
ATKVYA ILTHGIFSGPAISRINNAAFEAVV 269 
GCCACCAMGn;TATGCTATCCTTACCCATGGGA~ACCAGCTATTTCCA GAATAAATMTGCCGCCITTGAGGCTGTTGTC 810 
V T N T IPQEDKHKHC@KIQVI DISMILAEAI 
GTCA~CACM~CCGCAAGAGGACAAMn;AAACACnA TCTTGGCCGAAGCAATC 
299 
900 
RRTHNG E S V S YLFSHVPL* 
CGMGGACACACMn;GGGM~~~~~ACCIY;TTC 
TGACTTCTGACTTG Tl-FFFGTTITCK;GA~AGClGTAGGTA~ !IGATAGGl=FAATCACATCTTTG 
TATAn;~MGAmATTGmCC~~~GA~~~~~A~A 
AGTGMCTGTClTAAATGAGAAACGTTTlTG TCAT’M=lGAC!‘FITTMCAGGTACAGGTGA~~ GTAClTTGAG 
GCGACAACTTTCMGTATATMTITCATlGTGGMGTCATAGTTTATATATTFCGAGGlTGCCAMGGTGAC!lTCACATFAAAGCCTTCl’ 
GTGTAAATATATACTGATMTGCCTATGGACATTTGGG TAAAACCCTGTATAGAATTMTTATCCTTTFACTTTGGA GTGMCCTTGGAA 
MTTl’ATMTTATAATACCATGGA~MTT’lTC~-TMCl’CA GTlTCAGATAMCCAmAC 
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n;n;CTTMmGGACCAAA~A~AG~MTA~A~~A~~~ ATACATl’AGACATATCAGAGCAGTGTAT 
TTCTGGATCATTTITT AMTGAC CTCTTCTAMACATMCn;TCACTTACCTGAAATGCTGCA TccrMMTTccAAM TTATA’ITGAGC 
MTCGC~~CCTAMGCCMCPGACTTAMGGTM~~~MGA~~~~~~MGM~TATAGA~A~A 
AAATAATGATCTCAGATl’=FITAAAAAGGATATAGGMCCTGCAl-FGTCATTCTCFG MTTAAGAAC ATCATTATTTAGC! 1890 
CCCACCTlTGTATl’TTAAAATCCTTCAGMTACATlTATGMCCAATGCGA~ACTTAGCCACACACAATGGAAATTCAGAC~AC 1980 
TATTTGGTGTTTCCAGTTCkXAAGGTGATGMGACTG TCM’GGGAGCAGCTTMTCCCAAAATTTGTACA~CTCCTGGCG 2070 
TGGAAACTTAAGTGAGACCACCJUATACATTGGTCCTGTCCAATTCPACTGM~CCTGGCATTTA TCTGGCCAAAMCAGG 2160 
AGCCAGAGAAATAn;MTATACCAMGTn;TTTGmAGCCIY 2250 
TTCTTTlTAGATACTACATCAACTAGATTCAGGAGTATATCA- GTGCl-l’GTAlTGGTlTAAAA~MGATlTTMGATCCTCTA 2 3 4 0 
ACACTGTACI’AAAACATTI’CATAAAATCATTC%A~ 2397 
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Fig.2. Nucleotide and deduced amino acid sequences of human PRS 11 cDNA. Numbers in the right margin, nucleotides from the 
predicted initiation codon and amino acids beginning with 1 for the first amino acid of the mature protein. Amino acids are shown 
in single-letter codes. (*) Stop codon. Boxed residues, positions of the different amino acids from those of rat PRS II. Bar, putative 
PPRibP-binding site [14]. The polyadenylation signal is underlined. hhPRSll-9 and hhPRSll-15 covered from 30 to 2397 and from 
-60 to 1671, respectively. The number of dT stretch at nos 1478-1495 is 18 in the two clones hhPRSII-15 and AhPRSII-5, and 17 
in the one clone hhPRSII-9. Since the PRS 11 gene was located on chromosome X and cDNA was made from testis containing a single 
X, the sequence of 17 dTs may be an artifact, not a polymorphism. 
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plaques of a human testis cDNA library. Five of 
the clones were strongly hybridized with the rat 
PRS II probe: the inserts were 2.5, 2.4, 2.3, 2.1 
and 1.7 kb in length. A restriction map and the se- 
quencing strategies for the selected five clones are 
shown in fig. 1. Since the size of the human PRS II 
mRNA was estimated to be 2.7 kb, as determined 
by Northern blot analysis of human testis mRNA, 
using rat [9] and human (not shown) PRS II cDNA 
probes, the 2.4 kb (no.9) and 1.7 kb (no.15) 
cDNAs containing 2457 base pairs (bp) covered 
nearly the full length. 
The nucleotide and deduced amino acid se- 
quences of the overlapping cDNA are shown in 
fig.2. The ATG triplet at position I was deter- 
mined as the initiation codon, based on a sequence 
similar to those of rat PRS I and II cDNAs and on 
Kozak’s rule [lo]. The calculated molecular mass 
was 34638 Da, without the initiation methionine, a 
value in accord with that of the reported human 
enzyme subunit (34.5 kDa) [ll]. 
Homologies between human PRS II and rat PRS 
II were 88% for 954 bp coding sequence and 99% 
for 3 18 amino acid residues. Of the deduced amino 
acid sequence, three substitutions were observed 
between human and rat PRS II with Ala-159, 
Lys-162 and Thr-284 in human PRS II, instead of 
Thr, Arg and Ser in rat PRS II, respectively, as in- 
dicated by boxes in fig.2. These are conservative 
substitutions based on Dayhoff’s mutation data 
[12]. The putative PPRibP-binding site (fig.2) was 
identical to those of rat PRS I and II. 
As shown in table 1, the amino acid homology 
was the highest in enzymes known to be involved 
in nucleotide metabolism and glycolysis. Direct 
comparisons between a pair of known nucleotide 
sequences in coding regions facilitate evaluation of 
the fraction of numbers of sequence differences 
from the total synonymous sites (synonymous dif- 
ference, KS), i.e. sites at which nucleotide substitu- 
tions do not cause amino acid substitutions [13]. 
Notable findings are as follows: (i) the KS value of 
i’PRibP synthetase (0.495) is close to those of 10 
other groups of human and murine enzymes 
(0.440 f 0.068) without hypoxanthine-guanine 
phosphoribosyltransferase (0.255); (ii) there seems 
Table 1 
Comparison of enzymes involved in nucleotide metabolism and glycolysis with amino acid 
homology and synonymous difference between human and murine 
Human enzymes Chromo- Species Amino acid No. of KS’ 
somal homologyb total 
location” (Q) residuesb 
Pyruvate kinase (liver type) 1 rat 92 543 0.401 
Orotidine-5 ‘-monophosphate 
decarboxylase 3 mouseC 90 262’ 0.516 
Aldolase B 9 rat 95 364 0.396 
Lactate dehydrogenase A 11 rat 94 332 0.511 
Glyceraldehyde-3-phosphate 
dehydrogenase 12 rat 94 333 0.324 
Adenine phosphoribosyltransferase 16 mouse 82 180 0.432 
Aldolase A 16 rat 97 364 0.403 
Thymidylate synthetase 18 mouse 88 307 0.413 
Adenosine deaminase 20 mouse 83 352 0.548 
Hypoxanthine-guanine phospho- 
ribosyltransferase X mouse 96 218 0.255 
Glucose-6-phosphate dehydrogenase X rat 94 515 0.459 
Phosphoribosyl pyrophosphate 
synthetase subunit II Xd rat 99 318 0.495 
a From [(1985) Cytogenet. Cell Genet. 40, 1-823) 
b From [(1988) Nucleic Acids Res. suppl. 16, r403-r408] 
’ Partial sequence 
d From [4] 
’ KS value, synonymous difference (from [13]) 
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to be no distinction between the KS values of en- 
zymes, the genes of which are located on 
autosomes and X-chromosomes; and (iii) there is 
no significant correlation between the amino acid 
homology and KS values of the 12 groups (correla- 
tion coefficient = -0.337). The amino acid se- 
quence of PPRibP synthetase was strikingly 
conserved between humans and rats. Thus, during 
evolution, there may have been a highly selective 
constraint to maintain the structure of this protein 
for the unique catalysis of a pyrophosphoryl 
transfer reaction and/or tightly controlled 
regulatory functions. 
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